“Since we started putting these quarterly reports together in Q1 2021, we have seen the gene therapy pipeline steadily increase. Oncology and rare disease remain the most targeted therapeutic areas, ...
Informa, the global publishing, business intelligence and events company, announced late last week that it’s selling its pharma intelligence unit to the private-equity firm Warburg Pincus for about $2 ...
Informa agreed to sell its pharma intelligence business to New York-based investment fund Warburg Pincus for 1.9 billion pounds ($2.58 billion), the British events organiser announced on Thursday, ...
LONDON, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence and Saama Technologies today announced a strategic partnership enabling Informa's Citeline and Saama's Life Science Analytics ...
FDA Approvals – Since Q4 2021, one new genetically modified cell therapy has been approved and one new gene therapy has filed for approval. Carvykti, a CAR-T cell therapy developed by Legend Biotech ...
NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and Signals Analytics, the next generation advanced ...
FDA Approvals – Since Q4 2021, one new genetically modified cell therapy has been approved and one new gene therapy has filed for approval. Carvykti, a CAR-T cell therapy developed by Legend Biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results